Advanced Diagnostic and Treatment Updates for Canine and Feline Lymphoma

Dr. Musser is an associate professor and board-certified veterinary medical oncologist at Iowa State University. She received her veterinary medicine degree from the University of Illinois in 2010. She completed a 1-year rotating internship at VCA West Los Angeles, and then a 3-year medical oncology residency at North Carolina State University. She spent 3 years as a veterinary oncologist at two private specialty clinics in Connecticut before joining Iowa State in 2017.

Dr. Durham is a Professor of Pathology and Associate Dean of Education at the University of Pennsylvania School of Veterinary Medicine. She is a 2005 graduate of Penn Vet, completed residency and board certification in anatomic pathology in 2008, and received her MSEd in medical education from Penn’s Graduate School of Education in 2024. She served as residency director for 13 years, founded the Penn’s Comparative Pathology Core, and was ACVP’s inaugural Chief Operations Officer (2019–2024). Dr. Durham’s research and clinical interests center on cancer in domestic animals, with a particular focus on hematolymphoid neoplasia and comparative lymphoma subtyping.

Dr. Flory is a board-certified veterinary medical oncologist whose clinical and research interests focus on oncology care for companion animals, novel diagnostics and therapeutics for canine and feline cancers, quality of life, cancer monitoring, cancer genomics, liquid biopsy, and early-detection screening. She has maintained an active clinical practice caring for pets with cancer while mentoring interns and residents, co-founding and leading the clinical team at PetDx, and in her current role collaborating with a multidisciplinary team at Zoetis. Dr. Flory has led and contributed to studies on stage migration, cancer therapy, liquid biopsy, early cancer detection, cancer monitoring, and novel cancer therapeutics. Her work reflects longstanding collaborations with laboratory scientists and clinician-researchers and underscores a commitment to advancing diagnostic tools and treatment strategies that improve outcomes and quality of life for animals with cancer.

Dr. Kent is a Professor of Radiation Oncology and Director of the Center for Companion Animal Health at the UC Davis Weill School of Veterinary Medicine.  He received his DVM from UC Davis and did an internship at the University of Pennsylvania.  This was followed by a year in private practice before going on to do residencies in Medical and Radiation Oncology at UC Davis, where he also received his Master’s Degree in clinical research. He is an author on over 125 peer reviewed publications.  His main research interests include clinical outcomes for veterinary patients receiving radiotherapy and optimizing radioimmunotherapy.